| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |